Navigation Links
DermTech and Stiefel Laboratories, Inc. to Further Evaluate EGIR(TM) Technology
Date:7/15/2009

LA JOLLA, Calif., July 15 /PRNewswire/ -- DermTech, Inc., a biotechnology company developing non-invasive molecular diagnostics for the early detection of disease plus additional applications, announced that it has entered into the second part of a feasibility study using DermTech's advanced EGIR(TM) technology to help Stiefel identify specific genetic markers involved in acne. The two companies will now move forward with a proof-of-concept study to assess the use of the technology to understand the pathophysiology of acne.

Stiefel is the world's largest independent dermatology company.

"Stiefel is one of the dermatology industry's clear pioneers and is well known for innovation in the field," said George Schwartz, CEO, DermTech. "We are looking forward to together embarking on this study that will employ our advanced, genetic-based technology and believe it will appropriately be the first ever to assess the relationship between genetic changes in the skin over time and the observable clinical effects of a marketed acne treatment."

"Stiefel is committed to using the most advanced, reliable tools for the development and continued refinement of our dermatology products and candidates," said Gavin Corcoran, M.D., Chief Scientific Officer, Stiefel. "We believe that DermTech's EGIR technology, based on the most recent understanding and application of genetics to disease, offers a very strong fit with our mission to introduce breakthrough products."

About DermTech:

Headquartered in La Jolla, California, DermTech International (www.dermtech.com) is developing its proprietary EGIR(TM) (Epidermal Genetic Information Retrieval) technology for genomic-based, non-invasive disease detection, improved pharmaceutical R&D and personalized medicine to help direct appropriate treatment. The company's first product candidate in devel
'/>"/>

SOURCE DermTech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. DermTech and Rady Childrens Hospital-San Diego, Initiate Study to Understand Effects of Vitamin D as a Treatment for Atopic Dermatitis in Children and Young Adults
2. DermTech Names Herbert A. Fritsche, Ph.D., Chief of Clinical Chemistry at M.D. Anderson Cancer Center to Companys Scientific Advisory Board
3. DermTech Study on Melanoma Molecular Diagnostic to Be Presented at AACR
4. DermTech Is Issued U.S. Patent for the Early Detection, Staging and Monitoring of Melanoma
5. DermTech Appoints BioStatistical Pioneer, John Quackenbush, Ph.D., as a Member of the Companys Scientific Advisory Board
6. GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business
7. Barrier Therapeutics to Merge Into Stiefel Laboratories
8. Stiefel Laboratories Appoints Two New Members to Board of Directors
9. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) Tablets
10. Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents
11. Charleston Laboratories, Inc. Completes Exploratory Bioequivalence Study of CL-108
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Calif. , Dec. 19, 2014 Bina Technologies, ... USA) announced today that they have been acquired by ... is a privately held company that provides a ... next generation sequencing (NGS) data for the academic and ... Roche Sequencing Unit, and will continue to focus on ...
(Date:12/19/2014)... Today, TiFiber, Inc. ... facility and future company headquarters in Fort Smith, ... materials that safely and effectively control dangerous microorganisms. ... its historic, strong support for manufacturing, but also ... edge, technology-based companies such as TiFiber. , ...
(Date:12/19/2014)... iLab Solutions, the global leader in core ... as the new Director of Institutional Implementations and Sarah ... two new leadership positions were created to support iLab’s ... iLab continues to meet the needs of its growing ... has been deployed at over 450 core facilities across ...
(Date:12/19/2014)... , Dec. 18, 2014  Decision Resources Group ... dental biomaterial market will grow moderately through 2023 as ... and growing awareness of dental biomaterials all spur procedure ... such as China and ... bring dental procedures within reach for a larger proportion ...
Breaking Biology Technology:Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3
... 12 The Board of,Directors of Baxter International Inc. ... $0.2175 per share of Baxter common stock., This ... was,increased earlier this year by 30 percent. This quarterly ... record as of March 10, 2008., Baxter International ...
... Feb. 12 /PRNewswire-FirstCall/ . Maxygen, Inc.,(Nasdaq: MAXY ... of,improved protein drugs, today reported financial results for ... At December 31, 2007, cash, cash,equivalents and marketable ... December 31, 2006., "After a productive year ...
... Calif., Feb. 12 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ... therapies for the treatment of cancer and,hepatitis C ... has,begun in its clinical trial designed to evaluate ... chemotherapy in patients with advanced,breast cancer. The primary ...
Cached Biology Technology:Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 2Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 3Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 4Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 5Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 6Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer 2Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer 3Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer 4
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has ... in the APAC Region 2015-2019"  report to their ... in this market is advances in technology. With ... upgrade biometric solutions to the latest standard that ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Valencell, a ... it is seeing a staggering demand from its licensees ... the Company revealed, is not solely coming from fitness ... as well. "A wearable is only as ... result, accuracy is the ultimate driver in long-term mass ...
(Date:12/5/2014)... MOUNTAIN VIEW, Calif. , Dec. 4, 2014 ... and safety has boosted investments in new testing ... products has also given rise to a range ... driven by the requirements of Generation Y, which ... digital technologies. As a result, product development strategies ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... Sorority and the Orthopaedic Research and Education Foundation (OREF) ... to close the gap between basic research and patient ... of the American Academy of Orthopaedic Surgeons (AAOS), these ... areas of musculoskeletal health: Bio-enhanced ...
... paint containing dangerous,concentrations of lead is being sold in ... refusing to remove the paint from store shelves. , ... the lead content of paint in,Cameroon to protect public ... (OK International) and co-author of a new,research study about ...
... Rochelle, NY, Mar 19, 2013Chronic fatigue, a persistent lack ... at least three times more prevalent among adult survivors ... or adolescence than in the general adult population, according ... Young Adult Oncology (JAYAO), ( http://www.liebertpub.com/JAYAO ) a ...
Cached Biology News:AAOS awards recognize innovative orthopaedic research 2AAOS awards recognize innovative orthopaedic research 3AAOS awards recognize innovative orthopaedic research 4US company identified as manufacture of lead paint in Africa 2Are survivors of childhood leukemia and lymphoma at greater risk of chronic fatigue as adults? 2
The imaging screen-K (Kodak), is a 35 x 43 cm storage phosphor screen that is used for the quantitation and imaging of 32P, 33P, 35S, 14C, and 3H....
The external laser upgrade for the Molecular Imager FX adds a 635 nm external laser; the 555 nm long pass filter is replaced with a 605 nm band pass filter to distinguish Cy5 from 532 nm excitable dy...
The HQ505, 20 OptiGreen filter for the Molecular Imager FX is a band pass filter used for detection of Cy2 and FITC with 532 nm excitation....
The filter 605DF50 for the Molecular Imager FX is a band pass filter for ethidium bromide, SYPRO Red, SYPRO Ruby, Alexa Fluor 532 and 546, and Cy3 dyes when using the 635 nm laser....
Biology Products: